Lantheus Medical Imaging
MA - Bedford
Biotechnology3 H-1B visas (FY2023)Focus: Small Molecules for Imaging
Lantheus Medical Imaging is a life sciences company focused on Small Molecules for Imaging.
OncologyCardiovascularNephrologyMetabolic DiseasesRespiratory
Funding Stage
PUBLIC
Open Jobs
1
Products & Portfolio (2)
4 discontinued products not shown
Pipeline & Clinical Trials
Contrast enhanced pituitary magnetic resonance imaging
Pituitary AdenomaClinical Trials (1)
NCT07335315Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
N/AContrast Specific Echocardiogram Versus Left Ventricular Opacification (LVO) Imaging Settings
Contrast Echocardiography ImagingClinical Trials (1)
NCT04286100Contrast Specific Echocardiogram Versus Left Ventricular Opacification (LVO) Imaging Settings
N/ACarotid Contrast Enhanced Ultrasound
AtherosclerosisClinical Trials (1)
NCT05416385Carotid Intraplaque Neovascularization Combined With Stress Echo
N/APYLARIFY
Prostate CancerClinical Trials (1)
NCT05712473An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer
N/ABMS747158
Coronary Artery Disease (CAD)Clinical Trials (1)
NCT01085162A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)
N/ACan Ultrasound Replace Computed Tomography (CT) Scan in Those Unable to Have Computed Tomography (CT
Nephrotoxicity of CT Contrast AgentsClinical Trials (1)
NCT01151566Can Ultrasound Replace Computed Tomography (CT) Scan in Those Unable to Have Computed Tomography (CT) Contrast Agents
N/AEarly Detection of Broken Hearts in Cancer Patients
CardiotoxicityClinical Trials (1)
NCT02086695Early Detection of Broken Hearts in Cancer Patients
N/ATotal-body PET imaging
Prostate CancerClinical Trials (1)
NCT05160480A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
N/AIdentification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Coronary Artery DiseaseClinical Trials (1)
NCT01436773Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
N/AGadofosveset Triodium
Pulmonary EmbolismClinical Trials (1)
NCT01165892Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)
N/ADiagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocar
ThrombusClinical Trials (1)
NCT00539045Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction
N/ARetrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Ec
Cardiovascular DiseaseClinical Trials (1)
NCT01299649Retrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Echocardiography With or Without DEFINITY®
N/Abicycle stress echocardiography
Mitral Annulus CalcificationClinical Trials (1)
NCT04093973Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular Calcification
N/AGlucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere
Coronary Artery DiseasePET scan quantifying sympathetic denervation using [18F]-LMI1195
Sudden Cardiac ArrestClinical Trials (1)
NCT03493516Prediction of ARrhythmic Events With Positron Emission Tomography II
N/AEchocardiography: Value and Accuracy at REst and STress
Coronary Artery DiseaseClinical Trials (1)
NCT03674255Echocardiography: Value and Accuracy at REst and STress
N/AN/A
Clinical Trials (1)
NCT01135316Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
N/AUltrasound
AtheromaClinical Trials (1)
NCT03466255Early Detection of Cardiovascular Disease
N/Agadofosveset
HealthyClinical Trials (1)
NCT01431300Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants
N/A[Lu-177]-PNT2002
Castration-Resistant Prostatic CancerDefinity
EndoleaksClinical Trials (1)
NCT01005212Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm Repair
N/ABMS747158
Healthy VolunteersClinical Trials (1)
NCT00707538A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress
Phase 1[3H] BMS747158
Coronary Artery DiseaseClinical Trials (1)
NCT00930631Study of [3H] BMS747158 in Healthy Male Subjects
Phase 1LMI 1195-101
Heart FailureClinical Trials (1)
NCT00891241A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure
Phase 1Perflutren Lipid Microspheres
Adnexal MassClinical Trials (1)
NCT03297112Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery
Phase 1Piflufolastat F18
Pancreatic CancerClinical Trials (1)
NCT05394259A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
Phase 1BMS747158
HealthyClinical Trials (1)
NCT00707499A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158
Phase 1Technetium Tc99m Sestamibi
Kawasaki DiseaseClinical Trials (1)
NCT00162045A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
Phase 1/2N-acetylcysteine
AgingClinical Trials (1)
NCT01384591Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly
Phase 1/2LNTH2403 Phase 1 dose
Relapsed / Refractory OsteosarcomaClinical Trials (1)
NCT07357519Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
Phase 1/2Pembrolizumab
Metastatic Renal Cell Carcinoma64Cu-LNTH-1363S
Metastatic SarcomaClinical Trials (1)
NCT0629891664Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Phase 1/2BMS747158
IschemiaClinical Trials (1)
NCT00849108Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
Phase 2Definity
Renal Cell CarcinomaClinical Trials (1)
NCT01062178Efficacy of Ultrasound Contrast Agent to Assess Renal Masses
Phase 2Peflutren Lipid Microsphere Injectable Suspension
Liver DiseaseClinical Trials (1)
NCT00162058A Phase II Study of DMP 115 to Assess Focal Liver Lesions
Phase 2Perflutren lipid microsphere
Von-Hippel LindauClinical Trials (1)
NCT03907657Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
Phase 2Perflutren Lipid microsphere
Chronic Kidney DiseasesClinical Trials (1)
NCT03196076Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension
Phase 2LMI 1195
Heart FailureClinical Trials (1)
NCT01085175Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing
Phase 2Definity
Cardiac CatheterizationClinical Trials (1)
NCT03243942Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
Phase 2PSMA PET scan
Prostate Cancer DiagnosisClinical Trials (1)
NCT05820724PSMA PET Scan and mpMRI for Prostate Cancer Detection
Phase 2Phase 2/3
Clinical Trials (1)
NCT05247541Diagnosing Compartment Syndrome With SHAPE vs Elastography
Phase 2/3piflufolastat F 18
Clear Cell Renal Cell CarcinomaClinical Trials (1)
NCT07084909Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC
Phase 2/3DEFINITY®
Cardiac DiseaseClinical Trials (1)
NCT03719612DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
Phase 3Flurpiridaz F18
Coronary Artery DiseaseClinical Trials (1)
NCT01681524Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI
Phase 3DEFINITY
Cardiac DiseaseClinical Trials (1)
NCT03571672DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
Phase 3Ultrasound contrast agent
Hepatocellular CarcinomaClinical Trials (1)
NCT02764801Contrast-enhanced Ultrasound Evaluation of Chemoembolization
Phase 3Flurpiridaz F18
Coronary Artery DiseaseClinical Trials (1)
NCT01347710A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Phase 3Sestamibi
Kawasaki DiseaseClinical Trials (1)
NCT00162032A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
Phase 3PSMA PET/CT guided intensification of therapy
Prostate CancerClinical Trials (1)
NCT04557501PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
Phase 3Definity® Vial for
Ventricular Ejection FractionClinical Trials (1)
NCT00401687DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
Phase 4Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 6 approved products, 47 clinical trials
H-1B (2023): 3 approvals
Open Roles: 1 active job
Portfolio Health
Peak2 (33%)
LOE Approaching4 (67%)
6 total products
Hiring Trend
Stable
1
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
3
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub